Your browser doesn't support javascript.
loading
Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy.
Wrenger, Robin; Jüptner, Michael; Marx, Marlies; Zhao, Yi; Zuhayra, Maaz; Caliebe, Amke; Osmonov, Daniar; Lützen, Ulf.
Afiliación
  • Wrenger R; Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, Haus L, 24105, Kiel, Germany.
  • Jüptner M; Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, Haus L, 24105, Kiel, Germany.
  • Marx M; Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, Haus L, 24105, Kiel, Germany.
  • Zhao Y; Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, Haus L, 24105, Kiel, Germany.
  • Zuhayra M; Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, Haus L, 24105, Kiel, Germany.
  • Caliebe A; Institute of Medical Informatics and Statistics, Kiel University and University Hospital of Schleswig-Holstein (UKSH), Kiel, Germany.
  • Osmonov D; Department of Urology and Pediatric Urology, University Hospital of Schleswig-Holstein (UKSH), Kiel, Germany.
  • Lützen U; Department of Nuclear Medicine, Molecular Diagnostic Imaging and Therapy, University Hospital of Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, Haus L, 24105, Kiel, Germany. ulf.luetzen@uksh.de.
BMC Urol ; 22(1): 96, 2022 Jul 04.
Article en En | MEDLINE | ID: mdl-35788220

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: BMC Urol Asunto de la revista: UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: BMC Urol Asunto de la revista: UROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania